COVID Vaccine and Colquitt Regional Medical Center
Frequently Asked Questions (FAQs)
Q: Am I eligible to receive the COVID-19 vaccine?
A: Effective Thursday, March 25th anyone over the age of 16 may receive the vaccine.
Q: How can I get the vaccine?
A: Colquitt Regional is also offering COVID-19 vaccinations every Friday at our Drive-thru Vaccine Clinic located at Heritage Church. Appointments are required. To schedule an appointment please click here https://colquittregional.com/covid-19/vaccine-appointment or call 229-891-9380.
If your business, club or church would like to host a vaccine clinic please call our hotline at 229-891-9380. We do request that a minimum of 20 people attend the clinic.
The Southwest Georgia Health District is also offering appointments for the COVID-19 vaccine. You may schedule an appointment by calling 229-352-6567.
Q: Why should I consider getting the COVID-19 vaccine?
A: Personal protection – large population trials show 95% clinical effectiveness for the vaccine to prevent disease and greatly lessen the severity of symptoms in the limited people that may still contract the virus despite vaccination.
Decrease transmission – receiving the vaccine will not only protect you, but also others around you, including immediate family, coworkers, and friends. Decreasing transmission equates to saving lives.
Q: How does the vaccine work?
A: The COVID virus has characteristic “spikes” on the surface of the virus, which are actually proteins. The mRNA vaccines from Pfizer and Moderna teach the cells in your body to make these spikes, which then allows your body to learn how to fight off cells that contain the spikes. These vaccines are not the actual virus, which is one of the reasons there are only mild side effects. The vaccine is administered as 2 vaccines, spread 21 to 28 days apart (based on brand). Each dose is given as an IM injection.
Q: How many different forms of the vaccine are currently available?
A: Three forms of the vaccine are available, Pfizer, Moderna and Janssen (Johnson & Johnson). Colquitt Regional is administering the Pfizer vaccine.
Q: Which of the vaccines will I receive?
A: All vaccines administered by Colquitt Regional are Pfizer.
Q: Who reviewed and approved the vaccine?
A: Clinical data from Pfizer/BioNTech includes testing on 43,000 patients. The FDA advisory committee approved use of the vaccination after presenting study information to the Vaccines and Related Biological Products Advisory Committee (VRBPAC). After it was approved for use, subsequent endorsement has been issued by the CDC’s Advisory Committee on Immunization Practices (ACIP).
Q: What is an EUA?
A: Emergency Use Authorization, granted by the FDA, is based on compelling medical evidence. This designation allows a product to come to market, but with the disclaimer that it has not gone through the full FDA medication approval process. Several therapies used for the treatment of COVID-19 are also being used under an EUA (remdesivir, bamlanivimab, etc).
Q: Will I still have to wear a mask AFTER I get the vaccine?
A: Yes. In accordance with CDC guidelines, individuals should continue to wear masks in public places, even if they have received the vaccine or have antibodies.
Q: If I have been diagnosed with COVID in the past, or have tested positive for antibodies, should I receive the vaccine?
A: Yes. All patients that have been confirmed to have had COVID-19 should consider the vaccine. It is recommended that individuals wait 90 days after a positive test before receiving a vaccine.
Q: Should I receive the vaccine if I am pregnant or nursing?
A: The vaccine has not been studied extensively with pregnancy, and those who are or could become pregnant or currently breast feeding are encouraged to talk with their healthcare provider. The CDC/ACIP guidance does recommend vaccination among pregnant or nursing women who desire receiving the vaccine. More information can be found here:
Q: Should I trust a vaccine that was produced in only 11 months?
A: Historically, new drugs or vaccines can take up to 6 years for development and test through scientific methods prior to reaching the market. However, the US Government and World Health Organization dedicated unprecedented resources of scientists, labs, and money to accelerate the process. The genome for COVID-19 was already mapped prior to cases arriving in the United States. New technology methods as well as a lack of need for culturing the virus enabled acceleration of vaccine creation. Furthermore, the trials were also accelerated, allowing Phase 2 and 3 human studies to be conducted sooner and given priority review by appropriate medical review panels. Of note, the coronavirus vaccine is not the first vaccine to use an accelerated approval process – other vaccinations have gone through condensed processes in order to help stop the spread and transmission of communicable diseases, most recently the H1N1 flu virus.
Q: What side effects could I experience to the vaccine?
A: Pain at the injection site is the most common side effect. Other, less common side effects included tiredness, headache, muscle pain, chills, joint pain, and fever. Most side effects were reported after the 2nd dose.
Q: Does the vaccine contain fetal embryo cells?
Q: Is there a charge for the vaccine?
A: No. The vaccine is free of charge.